Analyst Ratings For NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND)
Today, Wedbush reiterated its Outperform rating on NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND) with a price target of $76.00.
Some recent analyst ratings include
- 5/15/2018-Wedbush Reiterated Rating of Outperform.
- 4/2/2018-Leerink Swann Reiterated Rating of Mkt Perform ➝ Market Perform.
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo Reiterated Rating of Buy.
Recent Trading Activity for NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND)
Shares of NASDAQ:ASND – Ascendis Pharma closed the previous trading session at 65.20 down -0.75 1.14% with 65.4000015258789 shares trading hands.